EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pulmonary hypertension and associated heart failure: New insights on emerging signalling pathways

Rosalinda Madonna iD, Elisa Montemaggi

European Journal of Clinical Investigation · 2025-08 · 55 (8)

DOI: 10.1111/eci.70038 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 28.03.2025. Verfasst von Rosalinda Madonna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical and Molecular Pathology and Critical Area, Cardiology Division, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Heart Failure, Hypertension, Pulmonary, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension associated with left heart disease (PH‐LHD) represents the hemodynamic condition at rest resulting from pathologies that affect the left ventricle and/or the left atrium. Among the left heart diseases, heart failure is the most frequent cause of PH. PH‐LHD is the most common cause of PH, accounting for 65–80% of diagnoses. Several drugs targeting specific signalling pathways involved in the pulmonary remodelling in PH‐LHD, including nitric oxide, MAP kinase and endothelin‐1, have been tested in randomized clinical trials (RCTs), with disappointing results in terms of efficacy and safety. Therefore, PH‐LHD still remains orphan of specific therapies able to counteract the pre‐ and post‐capillary remodelling of the pulmonary circulation. In this article, we will discuss the pathophysiology and molecular mechanisms of PH‐LHD. We will focus on the emerging signalling pathways involved in the pathophysiology of PH‐LHD that could suggest novel molecular targets for the treatment of this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHypertension, PulmonarySignal TransductionHumansNitric OxideEndothelin-1

Stichwörter der Autor:innen

activinbiomarkersheart failureleukocyte telomere lengthmiRNAmtDNAcn in peripheral blood cellspulmonary hypertension

Substanzen

Nitric OxideEndothelin-1

Autor:innen und Institutionen

  • Department of Surgical, Medical and Molecular Pathology and Critical Area, Cardiology Division, University of Pisa, Pisa, Italy.

ORCID-Profile: Rosalinda Madonna

Förderung

  • Ministero dell'Università e della Ricerca

Zitieren

APA

Madonna, R., & Montemaggi, E. (2025). Pulmonary hypertension and associated heart failure: New insights on emerging signalling pathways. European Journal of Clinical Investigation, 55(8). https://doi.org/10.1111/eci.70038

Vancouver

Madonna R, Montemaggi E. Pulmonary hypertension and associated heart failure: New insights on emerging signalling pathways. European Journal of Clinical Investigation. 2025;55(8). doi:10.1111/eci.70038

BibTeX
@article{Madonna2025,
  author = {Madonna, Rosalinda and Montemaggi, Elisa},
  title = {Pulmonary hypertension and associated heart failure: New insights on emerging signalling pathways},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  volume = {55},
  number = {8},
  doi = {10.1111/eci.70038}
}
Kostenlos starten →